Research.Patient.info

Acute myeloid leukemia and Blastic plasmacytoid dendritic cell neoplasm research hub

1 indexed studies · 0 currently recruiting

authorisedPhase I and Phase II (Integrated)- First administration to humans
Phase I/II Trial to Determine Safety and Efficacy of non-Viral Allogeneic Dual CD123/33-Chimeric Antigen Receptor CIK (CARCIK-CD123/33) Cells in Adult and Pediatric Patients with Relapse/Refractory Acute Myeloid Leukemia (AML) and Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
This clinical trial tests a new type of cell therapy for adults with hard-to-treat blood cancers, including acute myeloid leukaemia and BPDCN. Doctors want to see if specially modified donor immune cells are safe, find the right dose, and find out if they can help destroy stubborn cancer cells.
Italy